The Recombinant DNA Technology Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2019-2025. The Recombinant DNA Technology market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types and end industries. This Recombinant DNA Technology Market study provides comprehensive data that enhances the understanding, scope, and application of this report.
Top Companies in the Global Recombinant DNA Technology Market
Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc., Novo Nordisk, Sanofi, Merck KGaA, Profacgen, Biocon, GlaxoSmithKline, Cibus, Horizon Discovery Group, New England Biolabs.
Market Overview
Recombinant DNA technology (RDT) is performing a vital role in improving health conditions by developing new vaccines and pharmaceuticals. The treatment strategies are also improved by developing diagnostics kits, monitoring devices, and new therapeutic approaches. Additionally, many other industries are getting benefit from the Genetically Modified Organism (GMO) research such as microorganisms are being considered as future clean fuel producers and bio degrader. Genetically modified vaccines are developed for curing various diseases in human and plants. The recombinant DNA technology has created several potential innovation opportunities for developing a wide range of therapeutic products, with immediate effect in the medical genetics and biomedicine by modifying microorganisms, animals, and plants to yield medically useful substances. So, increasing demand, as well as the application of RDT in various sectors are acting as a major driver for the growth of the market.
Get Free Sample PDF Copy of Latest Research on Recombinant DNA Technology Market 2019 Before the purchase:
Key Market Trends
Food and Agriculture is Expected to Grow with High CAGR in the Forecasted Period
In agriculture development of genetically modified crops, with a purpose to improve both yield and resistance to plant pests, or herbicides seems to have gained a degree of public acceptance and is already practiced in a commercial context in several countries. The genetically modified tomato CGN-89564-2 was the first commercially grown, genetically engineered crop product to be granted a license for human consumption. Additionally, DNA molecular marker technology is important for preservation, identification, evaluation, mining, and innovation of plant germplasm resources. The introduction of a genetically modified fruit paved the way for use of GMOs in food, and today genetic modification is widespread. According to Journal of Applied Biotechnology and Bioengineering in 2016, in the United States, 88% of corn and 93% of soybeans are genetically altered and much of this finds it’s way unlabeled into processed foods. Thus, increased application of RDT in agriculture and food is augmenting the growth of the market.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. In the North America region, the United States holds the largest market share and this is due to the presence of number of biopharmaceutical manufacturing companies and presence of effective regulatory bodies to monitor the various ethical and scientific concerns, pertaining to the use of technology which has helped the growth of the Recombinant DNA (rDNA) Technology market in the country.
The Recombinant DNA Technology market can be divided based on product types and its sub-type, major applications and Third Party usage area, and important regions.
This report segments the global Recombinant DNA Technology Market on the basis of Types are:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
On The basis Of Application, the Global Recombinant DNA Technology Market is Segmented into:
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
(Exclusive Offer: Flat 30% discount on this report)
Inquire for Discount:
Regions are covered by Recombinant DNA Technology Market Report 2019 To 2025.
North America, Europe, China, Japan, Southeast Asia, India.
North America (USA, Canada and Mexico).
Europe (Germany, France, UK, Russia and Italy).
Asia-Pacific (China, Japan, Korea, India and Southeast Asia).
Significant Features that are under Offering and Key Highlights of the Reports:
-Detailed overview of Recombinant DNA Technology Market
-Changing Recombinant DNA Technology market dynamics of the industry
-In-depth market segmentation by Type, Application etc.
-Historical, current and projected Recombinant DNA Technology market size in terms of volume and value
Recent industry trends and developments
-Competitive landscape of Recombinant DNA Technology Market
-Strategies of key players and product offerings
-Potential and niche segments/regions exhibiting promising growth.
The report has 150 tables and figures browse the report description and TOC:
We Also Offer Customization on report based on specific client Requirement:
Free country Level analysis for any 5 countries of your choice.
Free Competitive analysis of any 5 key market players.
Free 40 analyst hours to cover any other data point.
In this study, the years considered to estimate the market size of Recombinant DNA Technology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
ABOUT US
Market Insights Reports is an online market research reports library of 500,000 in-depth studies of over 5000 micro markets. Market Insights Reports offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact Us
Irfan Tamboli – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
[email protected] | [email protected]
